Literature DB >> 10573370

Proliferating cell nuclear antigen expression in peribiliary glands of stone-containing intrahepatic bile ducts.

K T Lee1, P C Sheen.   

Abstract

All cases of hepatolithiasis showed features of chronic proliferative cholangitis, and it has been speculated that the atypical glandular proliferation might be a precursor to overt cholangiocarcinoma. Proliferative cell nuclear antigen (PCNA) is a nuclear protein synthesized in the G1/S phase of the cell cycle and therefore is related to cell proliferative activity. In an attempt to assess the activity of cell proliferation of stone-containing intrahepatic bile ducts, we conducted a study using immunohistochemical staining with monoclonal antibody to score PCNA in intrahepatic bile ducts. Thirty patients (10 men, 20 women; mean age 52.4 years) having hepatolithiasis surgically resected were studied. Ten stone-free patients served as controls. All 40 specimens were immunostained for PCNA using PC 10 monoclonal antibody. PCNA of both stone-containing and stone-free intrahepatic bile ducts were assessed by counting positive staining nuclei per 500 cells and expressed as labeling index (LI), ie, percentage of positive nuclei to the total number of nuclei. The PCNA LI in stone-free intrahepatic bile ducts was generally low: 10.0+/-13.2%, 10.4+/-10.7% and 7.9+/-9.6% for extramural glands, intramural glands, and epithelial lining, respectively. In contrast, the PCNA LI for stone-containing intrahepatic bile ducts were significantly higher than those of controls (P < 0.001): 49.4+/-8.3%, 40.6+/-7.0% and 34.1+/-6.8% for extramural glands, intramural glands, and epithelial lining, respectively. The extramural glands had a significantly higher PCNA LI (P < 0.001) than the intramural glands and controls. Hyperplasia was found in all specimens, while dysplasia was found in six of 30 cases with hepatolithiasis. The dysplastic cells also had a higher PCNA LI (P < 0.001) than the hyperplastic cells and normal epithelium. Our findings showed that there is marked increase of activity of cell proliferation in stone-containing intrahepatic bile ducts. It is well known that genetic mutations are facilitated in proliferating cells. Therefore, our results suggest that the high epithelial turnover in dysplastic cells and extramural glands had higher potential for proliferation and neoplastic transformation in long-standing untreated hepatolithiasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573370     DOI: 10.1023/a:1026604704029

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Autoantibody to a nuclear antigen in proliferating cells.

Authors:  K Miyachi; M J Fritzler; E M Tan
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

2.  Silver-binding nucleolar organizer regions in hepatolithiasis and bile duct cancer.

Authors:  C G Ker
Journal:  Proc Natl Sci Counc Repub China B       Date:  1997-04

Review 3.  Too many rodent carcinogens: mitogenesis increases mutagenesis.

Authors:  B N Ames; L S Gold
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

Review 4.  Hepatolithiasis: present status.

Authors:  F Nakayama; A Koga
Journal:  World J Surg       Date:  1984-02       Impact factor: 3.352

5.  Significance of intestinal metaplasia for the evolution of cancer in the biliary tract.

Authors:  S Kozuka; M Kurashina; M Tsubone; K Hachisuka; A Yasui
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

6.  Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma.

Authors:  Y Nakanuma; T Terada; Y Tanaka; G Ohta
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

7.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

8.  Role of intestinal metaplasia in the histogenesis of gastric carcinoma.

Authors:  J R Jass
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

9.  A reappraisal of cholangiocarcinoma in patient with hepatolithiasis.

Authors:  M F Chen; Y Y Jan; C S Wang; T L Hwang; L B Jeng; S C Chen; T J Chen
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

10.  Changes in the nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication.

Authors:  R Bravo; H Macdonald-Bravo
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  2 in total

1.  Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas.

Authors:  K T Lee; T S Liu
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

2.  Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma.

Authors:  King-Teh Lee; Tsan-Shium Liu
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.